1. Home
  2. VRA vs SNTI Comparison

VRA vs SNTI Comparison

Compare VRA & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$2.40

Market Cap

60.6M

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.23

Market Cap

53.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
SNTI
Founded
1982
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.6M
53.6M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
VRA
SNTI
Price
$2.40
$1.23
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$4.00
$9.00
AVG Volume (30 Days)
1.9M
4.4M
Earning Date
12-11-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$324,296,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.33
$150.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$1.15
52 Week High
$4.09
$5.43

Technical Indicators

Market Signals
Indicator
VRA
SNTI
Relative Strength Index (RSI) 54.86 34.56
Support Level $1.39 $1.15
Resistance Level $2.06 $1.29
Average True Range (ATR) 0.21 0.24
MACD -0.01 -0.09
Stochastic Oscillator 80.23 4.91

Price Performance

Historical Comparison
VRA
SNTI

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: